-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

How Do I Sequence Therapy for Marginal Zone Lymphomas?

Program: Education Program
Session: Indolent Lymphomas: Answers to Smoldering Questions
Hematology Disease Topics & Pathways:
Biological, Therapies, immunotherapy
Sunday, December 6, 2020, 11:55 AM-12:00 PM

Pier Luigi Zinzani, MD, PhD

Institute of Hematology "Seràgnoli", University of Bologna, Bologna, Italy

Disclosures: Zinzani: ADC THERAPEUTICS: Honoraria, Membership on an entity's Board of Directors or advisory committees; SERVIER: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; AUTOLUS: Honoraria, Membership on an entity's Board of Directors or advisory committees; MEI PHARMA: Honoraria, Membership on an entity's Board of Directors or advisory committees; INCYTE: Honoraria, Speakers Bureau; BAYER: Honoraria, Membership on an entity's Board of Directors or advisory committees; KARYOPHARM: Honoraria, Membership on an entity's Board of Directors or advisory committees; DEBIOPHARMA: Honoraria; TAKEDA: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; EUSAPHARMA: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; VERASTEM: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; JANSSEN: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; CELLTRION: Honoraria, Speakers Bureau; ROCHE: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; GILEAD: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; BMS: Honoraria, Speakers Bureau; KIRIN KYOWA: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; MERCK: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; TG THERAPEUTICALS: Honoraria, Membership on an entity's Board of Directors or advisory committees; ASTRAZENECA: Honoraria, Membership on an entity's Board of Directors or advisory committees; BEIGENE: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; HIKMA: Honoraria, Speakers Bureau; ABBVIE: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; ASTELLAS: Honoraria, Speakers Bureau.

OffLabel Disclosure: LENALIDOMIDE BORTEZOMIB UMBRALISIB IDELALISIB DUVELISIB COPANLISIB PARSACLISIB ZANOBRUTINIB